14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Wednesday, 24th Apr 2024 ALNY stock ended at $143.80. This is 1.55% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.76% from a day low at $143.52 to a day high of $147.49.
90 days $143.51 $188.69
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Sep 19, 2023 $179.02 $180.17 $175.42 $175.66 608 890
Sep 18, 2023 $183.62 $184.84 $178.21 $179.77 713 272
Sep 15, 2023 $191.64 $196.28 $182.63 $184.99 1 904 219
Sep 14, 2023 $200.00 $202.50 $188.45 $193.06 2 002 440
Sep 13, 2023 $211.65 $211.65 $211.65 $211.65 0
Sep 12, 2023 $204.24 $212.08 $202.87 $211.65 765 145
Sep 11, 2023 $201.57 $204.65 $196.67 $203.72 547 836
Sep 08, 2023 $201.25 $205.50 $200.52 $201.43 621 779
Sep 07, 2023 $201.14 $203.79 $200.18 $201.10 487 703
Sep 06, 2023 $201.50 $201.76 $197.03 $201.45 362 304
Sep 05, 2023 $200.83 $204.45 $199.30 $200.34 436 264
Sep 01, 2023 $199.14 $204.48 $199.14 $201.17 480 901
Aug 31, 2023 $197.50 $200.76 $197.16 $197.82 428 841
Aug 30, 2023 $194.46 $198.34 $194.46 $197.16 310 940
Aug 29, 2023 $191.67 $195.70 $190.97 $194.46 368 247
Aug 28, 2023 $189.99 $192.72 $189.76 $191.66 261 559
Aug 25, 2023 $186.55 $190.49 $186.39 $189.26 191 322
Aug 24, 2023 $189.72 $190.32 $183.73 $186.77 349 547
Aug 23, 2023 $190.40 $192.39 $189.10 $190.38 262 162
Aug 22, 2023 $189.13 $190.30 $187.62 $189.38 411 929
Aug 21, 2023 $186.70 $189.44 $183.41 $188.73 329 358
Aug 18, 2023 $182.19 $186.20 $181.87 $186.03 358 074
Aug 17, 2023 $183.13 $185.40 $182.41 $183.89 389 298
Aug 16, 2023 $179.35 $182.96 $179.00 $182.43 355 903
Aug 15, 2023 $180.00 $181.67 $178.64 $180.13 359 810
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT